Article
Pharma In Brief - Federal Court Of Appeal Finds That "Promised" Utility Need Not Be Coterminous With The Inventive Concept
AstraZeneca Canada Inc. (AstraZeneca) appealed from the decision of Justice Rennie of the Federal Court (reported as AstraZeneca Canada Inc. v. Apotex Inc., 2014 FC 638) holding that AstraZeneca's ‘653 Patent was invalid for lack of demonstrated or soundly predicted utility.
Norton Rose Fulbright Canada LLP
